These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3687249)

  • 1. [Latent prostatic cancer].
    Mehlhorn J
    Z Urol Nephrol; 1987 Aug; 80(8):441-7. PubMed ID: 3687249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Problems of so-called atypical hyperplasia of the prostate].
    Mehlhorn J
    Z Urol Nephrol; 1987 Jul; 80(7):379-85. PubMed ID: 2444040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of prostatic cancer.
    Hohbach C; Dhom G
    Scand J Urol Nephrol Suppl; 1980; 55():37-47. PubMed ID: 6938034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benign hyperplasia of the prostate--an autopsy analysis].
    Mehlhorn J
    Z Urol Nephrol; 1987 Jun; 80(6):323-8. PubMed ID: 2442920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostatitis from the morphologic viewpoint--an autopsy analysis].
    Mehlhorn J
    Z Urol Nephrol; 1987 May; 80(5):253-8. PubMed ID: 2441538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do clinically insignificant tumors of the prostate exist?
    Stamatiou K; Alevizos A; Mariolis A; Spiliopoulou C; Alevizou A; Bovis K; Sofras F
    Urol Int; 2008; 81(4):379-82. PubMed ID: 19077395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The aggressiveness of prostatic cancer in relation to classification and grading].
    Mehlhorn J
    Z Urol Nephrol; 1988 Apr; 81(4):203-11. PubMed ID: 3400348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between dysplastic lesions and latent cancers of the prostate. An analysis of 100 autopsies].
    Schütze U
    Z Urol Nephrol; 1984 Sep; 77(9):529-35. PubMed ID: 6209871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.
    Stamatiou K; Alevizos A; Agapitos E; Sofras F
    Prostate; 2006 Sep; 66(12):1319-28. PubMed ID: 16688747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathology and epidemiology of prostatic cancer].
    Böcking A
    Radiologe; 1984 Jan; 24(1):5-12. PubMed ID: 6709880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atypical hyperplasia and latent carcinoma of the prostate as an early stage of carcinoma].
    Yatani R; Yabana T; Soga T
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):714-9. PubMed ID: 3985641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
    Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
    Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How reliable is cancer diagnosis with needle biopsy of the prostate?].
    Mihatsch MJ; Ohnacker H; Oberholzer M; Spichtin HP; Eichenberger T; Perret E; Torhorst J
    Urologe A; 1983 Jul; 22(4):202-7. PubMed ID: 6684343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy.
    Kronz JD; Shaikh AA; Epstein JI
    Hum Pathol; 2001 Apr; 32(4):389-95. PubMed ID: 11331955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence and morphology of coexisting carcinomas of the urinary bladder and prostate].
    Weidhase A; Kunze E
    Verh Dtsch Ges Pathol; 1993; 77():142-6. PubMed ID: 7511273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.
    Stamatiou K; Alevizos A; Natzar M; Mihas C; Mariolis A; Michalodimitrakis E; Sofras F
    Asian J Androl; 2007 Mar; 9(2):229-33. PubMed ID: 16751999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The diagnostic value of "dysplastic" changes in the prostate].
    Mehlhorn J
    Zentralbl Pathol; 1991; 137(5):395-401. PubMed ID: 1801908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignancy grade and clinical stage T0-T3 in prostate cancer].
    Wernert N; Goebbels R; Dhom G
    Urologe A; 1986 Jan; 25(1):55-8. PubMed ID: 3962046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
    Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.